Medicare Enrolled

Dr. Aaleya Koreishi, MD

Cornea and External Diseases Specialist Physician · Arlington, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
801 ROAD TO SIX FLAGS W STE 131, Arlington, TX 76012
8179871248
Registered in NPPES since 2006
NPI: 1629188073 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Koreishi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Koreishi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Koreishi

Dr. Aaleya Koreishi is a cornea and external diseases specialist physician in Arlington, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Koreishi performed 1,829 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Koreishi received a total of $151,279 from 35 pharmaceutical and/or device companies across 497 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Koreishi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ 1,829 Medicare services $151,279 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,829
Medicare services
Bottom 45% in TX for cornea and external diseases specialist physician
Not available
Unique patients (not deduplicated)
$115
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
713 $63 $183
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
214 $91 $272
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
164 $112 $417
Cataract surgery with lens implant
Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision.
118 $384 $1,622
Ultrasound scan of cornea to determine thickness
An ultrasound procedure used to measure the thickness of the cornea.
113 $8 $39
Corneal topography and eye depth measurement
This procedure measures the curvature and depth of the cornea, the clear front surface of the eye.
108 $32 $238
Contact lens fitting for eye surface disease
This procedure involves the fitting of a contact lens specifically intended to treat or manage a disease affecting the surface of the eye.
97 $28 $128
CT scan of cornea
A computed tomography scan used to create detailed images of the cornea, the clear front part of the eye.
65 $24 $96
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
53 $75 $311
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
47 $50 $215
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
46 $237 $833
Corneal transplant, outer layer
Surgical procedure to replace the outer layer of the cornea with donor tissue.
29 $917 $3,007
Amniotic membrane placement on eye surface
This procedure involves placing amniotic membrane on the surface of the eye to promote wound healing.
25 $1,058 $3,700
Tear duct plug insertion
A procedure to insert a small plug into the tear duct opening to help retain tears on the eye surface.
13 $138 $574
Slit lamp examination of the eye
This procedure uses a specialized microscope to examine the front portion of the eye.
13 $24 $330
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
11 $76 $374
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
8.0% high complexity
9.7% medium
82.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$151,279
Total received (2018-2024)
Avg $21,611/year across 7 years
Top 7% in TX for cornea and external diseases specialist physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
497
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$26,242
2023
$26,988
2022
$18,624
2021
$15,978
2020
$11,840
2019
$29,876
2018
$21,731

Payments by company (2024)

Bausch & Lomb Americas Inc.
$25,126
Harrow Eye, LLC
$378
SUN PHARMACEUTICAL INDUSTRIES INC.
$263
Alcon Vision LLC
$120
ABBVIE INC.
$95
Tarsus Pharmaceuticals, Inc.
$80
Oyster Point Pharma, Inc.
$78
Dompe US, Inc.
$69
TearLab Corp
$17
BIOTISSUE HOLDINGS INC.
$15
Top 3 companies account for 98.2% of 2024 payments
All-time payments by company (2018-2024) ›
Bausch & Lomb Americas Inc.
$44,179
Shire North American Group Inc
$30,244
Dompe US, Inc.
$18,235
Oyster Point Pharma, Inc.
$15,974
Eyevance Pharmaceuticals LLC
$13,345
Novartis Pharmaceuticals Corporation
$12,293
Bausch & Lomb, a division of Bausch Health US, LLC
$6,196
Kala Pharmaceuticals, Inc.
$2,924
Johnson & Johnson Surgical Vision, Inc.
$1,960
Allergan, Inc.
$1,389
SUN PHARMACEUTICAL INDUSTRIES INC.
$1,119
Sun Pharmaceutical Industries Inc.
$512
Alcon Vision LLC
$442
NOVARTIS PHARMACEUTICALS CORPORATION
$438
Alcon Laboratories Inc
$392
Harrow Eye, LLC
$378
ABBVIE INC.
$285
Allergan Inc.
$200
TissueTech, Inc.
$100
BioTissue Holdings, Inc.
$82
Tarsus Pharmaceuticals, Inc.
$80
RxSight Inc
$79
EYEVANCE PHARMACEUTICALS LLC
$68
AbbVie, Inc.
$56
Ocular Therapeutix, Inc.
$47
Horizon Therapeutics plc
$45
RECORDATI_RARE_DISEASES_INC.
$41
Carl Zeiss Meditec AG
$39
Mallinckrodt Hospital Products Inc.
$26
TISSUETECH, INC.
$24
EUSA Pharma (US) LLC
$21
EyePoint Pharmaceuticals US, Inc.
$20
TearLab Corp
$17
BIOTISSUE HOLDINGS INC.
$15
Thea Pharma Inc.
$13
Top 3 companies account for 61.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVEFOCUS · ALPHAGAN P · ALREX · ARGOS · AcrySof IQ VIVITY IOL · BEOVU · BESIVANCE · BLINK NUTRITEARS · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · CEQUA · CYSTADROPS · Cequa · Clareon · DEXTENZA · DEXYCU · DUREZOL · ENVISTA TORIC · EYSUVIS · Flarex · Humira · INVELTYS · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LOTEMAX · LOTEMAX GEL · LOTEMAX SM · LUMIGAN · MIEBO · None Specified · ORA · OXERVATE · One Series Ultra · Oxervate · PROKERA · PROLENSA · Prokera · RESTASIS · RESTASIS MULTIDOSE · ReSTOR · ReSure Sealant · Rocklatan · ScoutPro Osmolarity System · Simbrinza · Sylvant · TEPEZZA · TYRVAYA · Tecnis 1-piece IOL · Tecnis Multifocal Family of 1-piece IOLS · Tecnis Simplicity · Tobradex ST · VEVYE · VUITY · VYZULTA · XDEMVY · XELPROS · XIIDRA · ZIRGAN · ZYLET · Zerviate
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a cornea and external diseases specialist physician in Arlington?
Compare cornea and external diseases specialist physicians in the Arlington area by procedure volume, costs, and industry payment transparency.
Browse cornea and external diseases specialist physicians nearby

Geographic Context

Cornea and external diseases specialist physicians in nearby ZIP areas
10
County median income
$81,905
Nearest hospital to ZIP centroid (approximate)
TEXAS HEALTH ARLINGTON MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Koreishi is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Koreishi experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Koreishi performed 713 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Koreishi receive payments from pharmaceutical companies?
Yes. Dr. Koreishi received a total of $151,279 from 35 companies across 497 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Koreishi's costs compare to other cornea and external diseases specialist physicians in Arlington?
Dr. Koreishi's average Medicare payment per service is $115. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Koreishi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →